Court Allows Sale of Vuse Menthol E-cigarette Pods
After the Fifth Circuit Court of Appeals in the United States issued a temporary stay on Monday, R.J. Reynolds Vapor is allowed to continue selling its Vuse products in two mint flavors that had been subject to a marketing denial order (MDO).
Last Friday, the US Food and Drug Administration (FDA) rejected R.J. Reynolds' PMTA for its Vuse alternative pod mint 4.8% (nicotine content) G1 and Vuse alternative pod mint 4.8% G2 tobacco products.
As a result, Renault will be prohibited from selling or distributing these products in the United States, or else it will face enforcement action from the US Food and Drug Administration. However, the appellate court's ruling allows these products to continue being sold in the market.
A similar incident occurred. In October of last year, the US Food and Drug Administration issued a marketing denial order (MDO) against several mint-flavored soda products sold by Logic Technology Development. This was the first time the FDA had issued an MDO against mint products after undergoing scientific review.
After several days, Logic Corporation obtained a court order from the U.S. Third Circuit Court of Appeals to temporarily suspend the order.
Related reading:
British American Tobacco seeks to halt FDA's marketing ban on two Vuse e-cigarette products.
This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.
